Yu-Lin Wu1, Chun-Jen Huang, Su-Chen Fang, Ling-Hsin Ko, Pei-Shan Tsai. 1. From the School of Nursing (Wu, Fang), College of Nursing, Taipei Medical University; Department of Anesthesiology (Huang), Wan Fang Hospital, Taipei Medical University; Graduate Institute of Clinical Medicine (Huang), College of Medicine, Taipei Medical University; Tungs' Taichung Metroharbor Hospital (Ko), Taichung; and School of Nursing (Tsai), College of Nursing, Taipei Medical University, Taiwan.
Abstract
OBJECTIVE: Cognitive dysfunction has been reported in individuals with fibromyalgia. However, findings regarding cognitive function examined using neuropsychological tests have been inconsistent. The aim of the study was to determine domain-specific cognitive impairment in patients with fibromyalgia compared with healthy controls. METHODS: We conducted a meta-analysis that systematically searched six databases (PubMed, Ovid MEDLINE, Embase, CINAHL, PsycINFO, and Web of Science) for articles published before September 2017. RESULTS: Twenty-three case-control studies with a total of 2096 participants were included in the meta-analysis. Cognitive function was significantly lower (g = 0.87, 95% confidence interval [CI] = 0.60-1.15) in individuals with fibromyalgia than in healthy controls. Large effect sizes were found in learning/memory and attention/psychomotor speed (g = 0.94, p = .013; g = 1.22, p < .001, respectively); medium effect sizes were reported in executive function and working memory (g = 0.72, p < .001; g = 0.75, p < .001, respectively). Depression and anxiety scores were associated with the effect size of group differences in cognitive function (B = 0.11, p < .001, 95% CI = 0.09-0.13; B = 0.02, p < .001, 95% CI = 0.01-0.02, respectively). CONCLUSIONS: Cognitive impairment across different cognitive domains was found in individuals with fibromyalgia compared with healthy controls. Mood states (depression and anxiety) may explain the heterogeneity across studies.
OBJECTIVE:Cognitive dysfunction has been reported in individuals with fibromyalgia. However, findings regarding cognitive function examined using neuropsychological tests have been inconsistent. The aim of the study was to determine domain-specific cognitive impairment in patients with fibromyalgia compared with healthy controls. METHODS: We conducted a meta-analysis that systematically searched six databases (PubMed, Ovid MEDLINE, Embase, CINAHL, PsycINFO, and Web of Science) for articles published before September 2017. RESULTS: Twenty-three case-control studies with a total of 2096 participants were included in the meta-analysis. Cognitive function was significantly lower (g = 0.87, 95% confidence interval [CI] = 0.60-1.15) in individuals with fibromyalgia than in healthy controls. Large effect sizes were found in learning/memory and attention/psychomotor speed (g = 0.94, p = .013; g = 1.22, p < .001, respectively); medium effect sizes were reported in executive function and working memory (g = 0.72, p < .001; g = 0.75, p < .001, respectively). Depression and anxiety scores were associated with the effect size of group differences in cognitive function (B = 0.11, p < .001, 95% CI = 0.09-0.13; B = 0.02, p < .001, 95% CI = 0.01-0.02, respectively). CONCLUSIONS:Cognitive impairment across different cognitive domains was found in individuals with fibromyalgia compared with healthy controls. Mood states (depression and anxiety) may explain the heterogeneity across studies.
Authors: Anna L Kratz; Daniel Whibley; Samsuk Kim; Martin Sliwinski; Daniel Clauw; David A Williams Journal: Arthritis Care Res (Hoboken) Date: 2020-11-09 Impact factor: 4.794
Authors: Amnon A Berger; Yao Liu; Jeanne Nguyen; Robert Spraggins; Devin S Reed; Christopher Lee; Jamal Hasoon; Alan D Kaye Journal: Orthop Rev (Pavia) Date: 2021-06-22
Authors: Carmen M Galvez-Sánchez; Pablo de la Coba; José M Colmenero; Gustavo A Reyes Del Paso; Stefan Duschek Journal: PLoS One Date: 2021-01-27 Impact factor: 3.240
Authors: Juan Luis Leon-Llamas; Santos Villafaina; Alvaro Murillo-Garcia; Narcis Gusi Journal: Int J Environ Res Public Health Date: 2021-02-06 Impact factor: 3.390
Authors: Florence B Pomares; Steve Roy; Thomas Funck; Natasha A Feier; Alexander Thiel; Mary-Ann Fitzcharles; Petra Schweinhardt Journal: Pain Date: 2020-01 Impact factor: 7.926